Dr. Andrea Love

I think a lot of it really is you have this kind of ecosystem where now it's the wellness industry and all these podcasters who are telling you the truth that the scientists and the doctors and the government are hiding from you. And that has led to the explosion of kind of this alt-right wellness industry.

And this has kind of converged with the growth of increasing health anxiety as a result of the COVID pandemic, where people were You know, they're looking for voices who are going to tell them the quick fixes to take control of their health.

And this has kind of converged with the growth of increasing health anxiety as a result of the COVID pandemic, where people were You know, they're looking for voices who are going to tell them the quick fixes to take control of their health.

And this has kind of converged with the growth of increasing health anxiety as a result of the COVID pandemic, where people were You know, they're looking for voices who are going to tell them the quick fixes to take control of their health.

That's exactly right. And I think this is actually something that is deliberately exploited by these people who are pushing the contrarian anti-science rhetoric, right? Whereas instead where we could be having a legitimate conversation about something like Tuskegee.

That's exactly right. And I think this is actually something that is deliberately exploited by these people who are pushing the contrarian anti-science rhetoric, right? Whereas instead where we could be having a legitimate conversation about something like Tuskegee.

That's exactly right. And I think this is actually something that is deliberately exploited by these people who are pushing the contrarian anti-science rhetoric, right? Whereas instead where we could be having a legitimate conversation about something like Tuskegee.

Right. And as a result of that, we have really strict laws about human subjects and human clinical research to avoid those things that were conducted very unethically.

Right. And as a result of that, we have really strict laws about human subjects and human clinical research to avoid those things that were conducted very unethically.

Right. And as a result of that, we have really strict laws about human subjects and human clinical research to avoid those things that were conducted very unethically.

Or when we talk about how women were not historically included proportionally in clinical trials and laws have been implemented and regulations have been implemented because we know as scientists and as healthcare providers that when we don't appropriately run clinical research where we include the actual groups of people that need to be represented, the data can be impacted, right?

Or when we talk about how women were not historically included proportionally in clinical trials and laws have been implemented and regulations have been implemented because we know as scientists and as healthcare providers that when we don't appropriately run clinical research where we include the actual groups of people that need to be represented, the data can be impacted, right?

Or when we talk about how women were not historically included proportionally in clinical trials and laws have been implemented and regulations have been implemented because we know as scientists and as healthcare providers that when we don't appropriately run clinical research where we include the actual groups of people that need to be represented, the data can be impacted, right?

That's why we talk about study design and sample size and why you can't use a mouse study to make human claims. And as a result, starting in the 90s, we've seen a dramatic improvement in participation in clinical trials, which then informs our therapeutic development. The infrastructure, the institutions have learned from this.

That's why we talk about study design and sample size and why you can't use a mouse study to make human claims. And as a result, starting in the 90s, we've seen a dramatic improvement in participation in clinical trials, which then informs our therapeutic development. The infrastructure, the institutions have learned from this.

That's why we talk about study design and sample size and why you can't use a mouse study to make human claims. And as a result, starting in the 90s, we've seen a dramatic improvement in participation in clinical trials, which then informs our therapeutic development. The infrastructure, the institutions have learned from this.

And these things were bad and that's been acknowledged and we're doing better as a result. What ends up happening is instead of talking about that, they say, oh, well, they don't care about you. That's why they did this. And we talk about things like how the FDA has really strict oversight. And then it's inevitably, well, the opioid epidemic.

And these things were bad and that's been acknowledged and we're doing better as a result. What ends up happening is instead of talking about that, they say, oh, well, they don't care about you. That's why they did this. And we talk about things like how the FDA has really strict oversight. And then it's inevitably, well, the opioid epidemic.

And these things were bad and that's been acknowledged and we're doing better as a result. What ends up happening is instead of talking about that, they say, oh, well, they don't care about you. That's why they did this. And we talk about things like how the FDA has really strict oversight. And then it's inevitably, well, the opioid epidemic.

And that is a really complex topic, but it completely derails any conversation about the thousands upon thousands upon thousands of medicines that are safe and regulated and overseen by the FDA.